William K. Hagmann - Concepedia

Author

William K. Hagmann

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

W Hagmann, William Hagmann, William K Hagmann, William K. Hagmann

120

Publications

7.2K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)United States Military Academy

About

William K. Hagmann is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	51	5.2K
2	Natural Sciences	16	20	4.4K
3	Engineering	7	7	229
4	Health Sciences	5	5	81
5	Public Health	1	1	17

William K. Hagmann

Publications

6.9K

Citations

H-Index

Page 1

	Year	Citations
The Many Roles for Fluorine in Medicinal Chemistry William K. Hagmann Journal of Medicinal Chemistry Medicinal ChemistryMolecular SciencesBioorganic ChemistryPharmaceutical ScienceBiochemistry	2008	3.5K
[<sup>18</sup>F]MK-9470, a positron emission tomography (PET) tracer for<i>in vivo</i>human PET brain imaging of the cannabinoid-1 receptor H. Donald Burns, Koen Van Laere, Sandra Sanabria Bohórquez, Proceedings of the National Academy of Sciences	2007	311
Stromelysin‐1: Three‐dimensional structure of the inhibited catalytic domain and of the C‐truncated proenzyme Joseph W. Becker, Alice I. Marcy, Laura L. Rokosz, Protein Science	1995	292
Potent, orally absorbed glucagon receptor antagonists Stephen E. de Laszlo, Candice Hacker, Bing Li, Bioorganic & Medicinal Chemistry Letters G Protein-coupled ReceptorMedicineFunctional SelectivityPhysiologyPharmacotherapy	1999	169
Cephalosporin antibiotics can be modified to inhibit human leukocyte elastase James B. Doherty, Bonnie M. Ashe, Lawrence W. Argenbright, Nature AntibioticsMedicineAntibiotic AdjuvantImmunologyCephalosporin Antibiotics	1986	166
The NMR structure of the inhibited catalytic domain of human stromelysin–1 Paul R. Gooley, Juliette O’Connell, Alice I. Marcy, Nature Structural & Molecular Biology Human Stromelysin–1BiochemistryNmr StructureNatural SciencesMolecular Biology	1994	154
Discovery of <i>N</i>-[(1<i>S</i>,2<i>S</i>)-3-(4-Chlorophenyl)-2- (3-cyanophenyl)-1-methylpropyl]-2-methyl-2- {[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), a Novel, Acyclic Cannabinoid-1 Receptor Inverse Agonist for the Treatment of Obesity Linus S. Lin, Thomas J. Lanza, James P. Jewell, Journal of Medicinal Chemistry Cannabis UseMolecular PharmacologyMedicinal ChemistryCompound 48Biochemistry	2006	122
Substituted Imidazoles as Glucagon Receptor Antagonists Linda L. Chang, Kelly L. Sidler, Margaret A. Cascieri, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistryMedicineSubstituted ImidazolesMechanism Of Action	2001	108
Human fibroblast stromelysin catalytic domain: expression, purification, and characterization of a C-terminally truncated form Alice I. Marcy, Laura L. Eiberger, Richard K. Harrison, Biochemistry	1991	92
Characterization of a Novel, Non-peptidyl Antagonist of the Human Glucagon Receptor Margaret A. Cascieri, Gregory Koch, Elżbieta Ber, Journal of Biological Chemistry	1999	92

Page 1